fda warning bpc-157 not approved safety risks Regulatory Alert: The Legal Status of in Compounding and Clinical Practice – Holt Law The Hidden Risks of BPC‑157:

3.3 Hair Growth Stimulation: It promotes hair follicle proliferation and inhibits 5-alpha-reductase (like minoxidil), reducing DHT-related hair loss

You may know that each GP Practice is governed by a CCG and each CCG has a Medicines Optimisation Department the role of this department is to make sure that the right patients get the right choice of medicine at the right time

Compared to anti-inflammatory peptides such as LL-37 or cathelicidins, BPC-157 does not display direct antimicrobial activity but modulates the immune-vascular axis in a more refined manner

[Google Scholar] 81.Stupnisek M., Kokot A., Drmic D., Hrelec Patrlj M., Zenko Sever A., Kolenc D., Radic B., Suran J., Bojic D., Vcev A., et al